Blood glucose monitoring device for evaluating night hypoglycemia of type 2 diabetic patient

Abstract

The invention provides a blood glucose monitoring device for evaluating night hypoglycemia of a type 2 diabetic patient in order to solve the problems in the prior art. The blood glucose monitoring device comprises an infrared measurement and control glove, an analysis and monitoring system and a measurement and control arm guard. The analysis and monitoring system comprises a processor, an alarm,a wireless module and a power module, wherein the alarm and the wireless module are in signal connection with the processor. The infrared measurement and control glove comprises a glove body. A plurality of LED infrared lamps arranged in a matrix mode are fixed to the inner wall of the glove body through flexible conductive plates. Flexible light sensing plates are attached to the outer sides ofthe LED infrared lamps. The measurement and control arm guard comprises an arm guard sleeve. A flexible pipe penetrating through the inner side and the outer side of the arm guard sleeve is fixed to the arm guard sleeve. The end, located on the inner side of the arm guard sleeve, of the flexible pipe is communicated with an indwelling needle, and the end, located on the outer side of the arm guardsleeve, of the flexible pipe is communicated with a blood glucose meter through an electric control valve. The blood glucose monitoring device can monitor the blood glucose level of the patient in real time without affecting the dormancy of the patient, and the problem that existing infrared light detection is inaccurate is effectively solved.

Description

technical field [0001] The invention relates to the field of medical equipment, in particular to a blood sugar monitoring device for evaluating nocturnal hypoglycemia in patients with type 2 diabetes. Background technique [0002] Type 2 diabetes, formerly known as adult-onset diabetes, usually occurs after the age of 35 to 40, accounting for more than 90% of diabetic patients. The ability to produce insulin in the body of patients with type 2 diabetes is not completely lost, and some patients even produce too much insulin in the body, but the effect of insulin is poor, so the insulin in the body of the patient is relatively deficient, which can be stimulated by some oral drugs Insulin secretion. However, some patients still need to use insulin therapy in the later stage. [0003] Because patients with type 2 diabetes generally need to take medication during the day, it sometimes causes hypoglycemia when the patient sleeps at night. General hypoglycemia can cause discomfo...

AI Technical Summary

Problems solved by technology

The ability to produce insulin in the body of patients with type 2 diabetes is not completely lost. Some patients even produce too much insulin in the body, but the effect of insulin is poor. Therefore, the insulin in the body of the patient is relatively deficient. insulin secretion

Existing blood sugar detection generally uses fingertip blood sampling, which is more painful for patients and is not conducive to sleeping at night

Or use non-invasive saliva testing, but it is difficult to collect saliva at night when the patient sleeps without disturbing their sleep

The existing non-invasive infrared light detection does not affect the patient's night rest, but there will be a problem of inaccurate detection when the patient turns the body

Images